Funding boost for GSK's open innovation research into diseases affecting the developing world
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Lundbeck is well on track to deliver on guidance for 2013
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
Bayer: Life Sciences off to a good start in anniversary year
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Bristol-Myers Squibb reports first quarter 2013 financial results
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
AstraZeneca first quarter results 2013
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Novartis delivered solid performance in the first quarter
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Abbott reports first-quarter 2013 results
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
More Pharma News ...
- Daiichi Sankyo and Ranbaxy launch hybrid business in Brazil to expand business of both companies
- Roche Group posts strong sales growth in the first quarter
- Lundbeck announces positive results for Brintellix™ (vortioxetine)
- Astellas and Ambrx initiate collaboration for discovery and development of antibody drug conjugates for oncology
- MedImmune, AstraZeneca's biologics unit, acquires AlphaCore Pharma
- Supreme Court denial of Glivec patent clarifies limited intellectual property protection and discourages future innovation in India
- FDA perspective published in the New England Journal of Medicine reinforces safety of Pradaxa® (dabigatran etexilate)